Widzowski
Dan Widzowski, Wilmington DE
Patent application number | Description | Published |
---|---|---|
20100168146 | Composition Comprising (R)-Spiro[L-Azabicyclo[2.2.2]Octane-3,2'(3'H)-Furo[2,3-B]Pyridine (AZD0328) and its Use in the Treatment of Alzheimer's Disease, ADHD or Cognitive Dysfunction - A pharmaceutical composition comprising (R)-spiro[1-azabicyclo[2.2.2]octane-3,2′(3′H)-furo[2,3-b]pyridine (AZD0328) and its use in the treatment of subjects suffering from schizophrenia, Alzheimer's disease or other conditions with impaired cognitive function. | 07-01-2010 |
Dan Widzowski, Wilmington, DE US
Patent application number | Description | Published |
---|---|---|
20080242688 | Method 741 - Methods of treatment and pharmaceutical compositions for providing improved cognition in subjects suffering from schizophrenia, Alzheimer's disease or other conditions with impaired cognitive function. | 10-02-2008 |
20090215841 | D2 Receptor Ligand-078 - This invention relates to the compound of Formula I and pharmaceutically acceptable salts thereof: | 08-27-2009 |
20090318415 | DIBENZOTHIAZEPINE DERIVATIVES AND USES THEREOF - 424 - Compounds the following formula: | 12-24-2009 |
20100093700 | Methods of Treating Mood Disorders - A method of treating at least one symptom or condition associated with but not limited to: Mood Disorders including but not limited to a) Depressive Disorders, including but not limited to, Major Depressive Disorder and Dysthymic Disorder and b) Bipolar Depression and/or Bipolar mania including but not limited to Bipolar I Disorder, including but not limited to those with manic, depressive or mixed episodes, and Bipolar II Disorder, c) Cyclothymic Disorder, and d) Mood Disorder Due to a General Medical Condition, comprising administering an effective amount of formula (I) or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of formula (I) or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier or diluent. | 04-15-2010 |
20120202991 | DIBENZOTHIAZEPINE DERIVATIVES AND USES THEREOF - 424 - Compounds the following formula: | 08-09-2012 |
Dan Widzowski, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20110160184 | Dibenzothiazepine Derivatives and Use Thereof - Compounds the following formula: wherein Z is as described in the specification, pharmaceutically acceptable salts thereof, compositions comprising the same, and methods of treating bipolar disorder, an anxiety disorder, a mood disorder or schizophrenia or other psychotic disorder with said compounds. | 06-30-2011 |
Dan Widzowski US
Patent application number | Description | Published |
---|---|---|
20110237568 | CRYSTALLINE FORMS - 11-piperazin- | 09-29-2011 |